Increased Serum Leptin Concentrations in Patients with Chronic Stable Angina Pectoris and ST-Elevated Myocardial Infarction

Abstract

Leptin is an adipocytokine that is produced mainly by adipose tissue; it is also identified in atherosclerotic lesions in human coronary atherosclerosis. However, the relation of serum leptin concentrations to ischemic heart disease (IHD) is still obscure. The aims of the present study were to investigate serum leptin concentrations in patients with ST-elevated myocardial infarction (STEMI) and with chronic stable angina pectoris (CSAP) and to evaluate the possible correlations of leptin to other atherosclerotic risk factors; including serum high sensitive C-reactive protein (Hs-CRP), serum homocysteine, and fibrinogen concentrations. For this purpose, 35 patients with CSAP, 40 with acute STEMI, and 30 control subjects with normal findings from coronary angiography were taken into the study prospectively. Serum leptin concentrations were significantly higher in patients with CSAP and STEMI compared to the control group (7.74 ±1.34 vs 6.37 ±1.85 ng/mL, p=0.021 and 8.22 ±3.13 vs 6.37 ±1.85 ng/mL, p=0.023, respectively). In addition, serum homocysteine concentrations were significantly increased in patients with CSAP (15.23 ±5.96 vs 11.40 ±2.11 μmol/L, p=0.025) and patients with STEMI (15.90 ±5.02 vs 11.40 ±2.11 μmol/L, p=0.012) compared to the control group. Serum fibrinogen concentrations were significantly increased only in the CSAP group as compared to controls (4.15 ±1.39 vs 3.45 ±1.19 g/L, p=0.025). No significant correlation was found between leptin levels and selected risk factors. In conclusion, serum leptin concentrations were significantly higher in both the CSAP and STEMI groups. However, owing to the lack of correlation between the leptin levels and selected classical coronary risk factors, it may be considered that leptin can be evaluated as one of the independent risk factors for IHD. Further randomized and controlled studies will be required to determine the pathophysiological meaning of the increased leptin levels and the central role between adipocyte function and atherosclerosis.

Get full access to this article

View all access options for this article.

References

Caprio M , Fabbrini E , Isidori AM , et al : Leptin in reproduction. Trends Endocrinol Metab 12:65-72, 2001.

Baratta M : Leptin—from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit 8:282-292, 2002.

Frühbeck G : A heliocentric view of leptin. Proc Nutr Soc 60:301-318, 2001.

Caro JF , Sinha MK , Kolaczynski JW , et al : Leptin: The tale of an obesity gene. Diabetes 45:1455-1462, 1996.

Hubert HB , Feinleib M , McNamara PM , et al : Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968-977, 1983.

Manson JE , Colditz GA , Stampfer MJ , et al : A prospective study of obesity and risk of ischemic heart disease in women. N Engl J Med 322:882-889, 1990.

Al Suwaidi J , Higano ST , Hamasaki S , et al : Association between obesity and coronary atherosclerosis and vascular remodeling. Am J Cardiol 88:1300-1303, 2001.

Eckel RH , Krauss RM : American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 97:2099-2100, 1998.

Soderberg S , Ahren B , Stegmayr B , et al : Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 30:328-337, 1999.

10.

Soderberg S , Olsson T , Eliasson M , et al : Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med 245:533-543, 1999.

11.

Agata J , Masuda A , Takada M , et al : High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 10:1171-1174, 1997.

12.

Courten M , Zimmet P , Hodge A , et al : Hyperleptinemia: The missing link in the metabolic syndrome? Diabet Med 14:200-208, 1997.

13.

Parhami F , Tintut Y , Ballard A , et al : Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ Res 88:954-960, 2001.

14.

Leyva F , Anker SD , Egerer K , et al : Hyperleptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 19:1547-1551, 1998.

15.

Winnicki M , Phillips BG , Accurso V , et al : Independent association between plasma leptin levels and heart rate in heart transplant recipients. Circulation 104:384-386, 2001.

16.

Leyva F , Godsland IF , Ghatei M , et al : Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18: 928-933, 1998.

17.

Wallace AM , McMahon AD , Packard CJ , et al : Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052-3056, 2001.

18.

Gomez-Ambrossi J , Salvador J , Paramo JA , et al : Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35:315-320, 2002.

19.

Das UN : Is obesity an inflammatory condition? Nutrition 17:953-966, 2001.

20.

Invitti C : Obesity and low-grade systemic inflammation. Minerva Endocrinol 27:209-214, 2002.

21.

Silha JV , Krsek M , Skrha JV , et al : Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur J Endocrinol 149:331-335, 2003.

22.

Makris T , Stavroulakis G , Krespi P , et al : Elevated plasma immunoreactive leptin levels preexist in off-spring of patients with essential hypertension. Am Heart J 138:922-925, 1999.

23.

Makris TK , Hatzizacharias AN , Krespi PG , et al : Markers of risk in young offspring with paternal history of myocardial infarction. Int J Cardiol 89:287-293, 2003.

24.

Soderberg S , Ahren B , Jansson JH , et al : Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409-418, 1999.

25.

Coillard C , Lamarche B , Mauriege P , et al : Leptinemia is not a risk factor for ischemic heart disease in men. Diabetes Care 5:782-786, 1998.

26.

Jacques PF , Bostom AG , Wilson PW , et al : Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73:613-621, 2001.

27.

Das S , Reynolds T , Patnaik A , et al : Plasma homocysteine concentrations in type II diabetic patients in India: Relationship to body weight. J Diabetes Complications 13:200-203, 1999

28.

Yuan J-M , Yu MC : Effect of obesity on plasma homocysteine: Author reply. Am J Clin Nutr 74:558-559, 2001.

29.

Tsioufis C , Antoniadis D , Stefanadis C , et al : Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am J Hypertens 15:600-604, 2002.